Metabolic syndrome alters relationships between cardiometabolic variables, cognition and white matter hyperintensity load

[1]  J. Betz,et al.  Association Between Microvascular Retinal Signs and Age-Related Hearing Loss in the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). , 2019, JAMA otolaryngology-- head & neck surgery.

[2]  A. Brickman,et al.  The effect of white matter hyperintensities on cognition is mediated by cortical atrophy , 2018, Neurobiology of Aging.

[3]  P. Mattos,et al.  Metabolic Syndrome and cognitive decline in the elderly: A systematic review , 2018, PloS one.

[4]  Stephen C Strother,et al.  The effect of white matter hyperintensities on verbal memory , 2018, Neurology.

[5]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[6]  S. Craft,et al.  Triglycerides cross the blood–brain barrier and induce central leptin and insulin receptor resistance , 2017, International Journal of Obesity.

[7]  C. Jack,et al.  Diabetes, Prediabetes, and Brain Volumes and Subclinical Cerebrovascular Disease on MRI: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS) , 2017, Diabetes Care.

[8]  J. Brüning,et al.  Neuronal control of peripheral insulin sensitivity and glucose metabolism , 2017, Nature Communications.

[9]  Ludovica Griffanti,et al.  Classification and characterization of periventricular and deep white matter hyperintensities on MRI: A study in older adults , 2017, NeuroImage.

[10]  Sudha Seshadri,et al.  Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association , 2016, Hypertension.

[11]  Roland Opfer,et al.  MRI FLAIR lesion segmentation in multiple sclerosis: Does automated segmentation hold up with manual annotation? , 2016, NeuroImage: Clinical.

[12]  V. Lioutas,et al.  Cognitive decline in metabolic syndrome is linked to microstructural white matter abnormalities , 2016, Journal of Neurology.

[13]  M. de Andrade,et al.  Cohort profile: the Baependi Heart Study—a family-based, highly admixed cohort study in a rural Brazilian town , 2016, BMJ Open.

[14]  David A. Bennett,et al.  White matter hyperintensities, incident mild cognitive impairment, and cognitive decline in old age , 2016, Annals of clinical and translational neurology.

[15]  Sterling C. Johnson,et al.  Long-term Variability in Glycemic Control Is Associated With White Matter Hyperintensities in APOE4 Genotype Carriers With Type 2 Diabetes , 2016, Diabetes Care.

[16]  W. Wen,et al.  Fasting blood glucose levels are associated with white matter hyperintensities’ burden in older individuals with and without type 2 diabetes , 2015, Journal of the Neurological Sciences.

[17]  E. Ettorre,et al.  Executive dysfunction assessed by Clock‐Drawing Test in older non‐demented subjects with metabolic syndrome is not mediated by white matter lesions , 2015, Psychiatry and clinical neurosciences.

[18]  P. Scheltens,et al.  White matter hyperintensities, cognitive impairment and dementia: an update , 2015, Nature Reviews Neurology.

[19]  Heung-Kook Choi,et al.  Grading and Interpretation of White Matter Hyperintensities Using Statistical Maps , 2014, Stroke.

[20]  Denise C. Park,et al.  How Does it STAC Up? Revisiting the Scaffolding Theory of Aging and Cognition , 2014, Neuropsychology Review.

[21]  P. Nederkoorn,et al.  Presence and progression of white matter hyperintensities and cognition , 2014, Neurology.

[22]  S. Waldstein,et al.  Association of fasting glucose with subclinical cerebrovascular disease in older adults without Type 2 diabetes , 2014, Diabetic medicine : a journal of the British Diabetic Association.

[23]  Benjamin S. Aribisala,et al.  Blood Pressure, Internal Carotid Artery Flow Parameters, and Age-Related White Matter Hyperintensities , 2014, Hypertension.

[24]  M. van Buchem,et al.  Microstructural Brain Tissue Damage in Metabolic Syndrome , 2014, Diabetes Care.

[25]  J A Maldjian,et al.  Automated White Matter Total Lesion Volume Segmentation in Diabetes , 2013, American Journal of Neuroradiology.

[26]  Nora Mattek,et al.  Neuropathologic basis of white matter hyperintensity accumulation with advanced age , 2013, Neurology.

[27]  D. Bennett,et al.  Very low levels of education and cognitive reserve , 2013, Neurology.

[28]  Wiro J Niessen,et al.  High Blood Pressure and Cerebral White Matter Lesion Progression in the General Population , 2013, Hypertension.

[29]  Y. Stern.  Cognitive reserve in ageing and Alzheimer's disease , 2012, The Lancet Neurology.

[30]  A. Brickman,et al.  Metabolic syndrome and localization of white matter hyperintensities in the elderly population , 2012, Alzheimer's & Dementia.

[31]  Yi Zeng,et al.  High normal plasma triglycerides are associated with preserved cognitive function in Chinese oldest-old. , 2012, Age and ageing.

[32]  Roger Tam,et al.  The association between cognitive function and white matter lesion location in older adults: a systematic review , 2012, Alzheimer's & Dementia.

[33]  Bernhard Hemmer,et al.  An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis , 2012, NeuroImage.

[34]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[35]  Evan Fletcher,et al.  Episodic memory function is associated with multiple measures of white matter integrity in cognitive aging , 2011, Front. Hum. Neurosci..

[36]  H. Bokura,et al.  The Association of Metabolic Syndrome with Executive Dysfunction Independent of Subclinical Ischemic Brain Lesions in Japanese Adults , 2011, Dementia and Geriatric Cognitive Disorders.

[37]  A. Silman,et al.  Association of cognitive performance with the metabolic syndrome and with glycaemia in middle‐aged and older European men: the European Male Ageing Study , 2010, Diabetes/metabolism research and reviews.

[38]  H. Markus,et al.  The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[39]  L. Pantoni.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.

[40]  J. Witteman,et al.  Insulin-resistance and metabolic syndrome are related to executive function in women in a large family-based study , 2010, European Journal of Epidemiology.

[41]  E. A. M. Gale,et al.  The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation , 2010, Diabetologia.

[42]  M. Jokela,et al.  Metabolic Syndrome Over 10 Years and Cognitive Functioning in Late Midlife , 2009, Diabetes Care.

[43]  Chan Soo Shin,et al.  Cerebral white matter hyperintensity is mainly associated with hypertension among the components of metabolic syndrome in Koreans , 2009, Clinical endocrinology.

[44]  C. Iadecola,et al.  Threats to the Mind: Aging, Amyloid, and Hypertension , 2009, Stroke.

[45]  C. Franceschi,et al.  Association of metabolic syndrome with cognitive function: the role of sex and age. , 2008, Clinical nutrition.

[46]  C. Iadecola,et al.  Hypertension and cerebrovascular dysfunction. , 2008, Cell metabolism.

[47]  M. de Andrade,et al.  Heritability of cardiovascular risk factors in a Brazilian population: Baependi Heart Study , 2008, BMC Medical Genetics.

[48]  F. Schmidt.  Meta-Analysis , 2008 .

[49]  K. Park,et al.  Significant association between leukoaraiosis and metabolic syndrome in healthy subjects , 2007, Neurology.

[50]  A. D. de Craen,et al.  The metabolic syndrome is associated with decelerated cognitive decline in the oldest old , 2007, Neurology.

[51]  Gary A. Ford,et al.  Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure , 2007, Journal of Neurology.

[52]  P. Sachdev,et al.  Ocular dipping and ping-pong gaze in hypoxic encephalopathy , 2007, Neurology.

[53]  Ramona O Hopkins,et al.  Prevalence of White Matter Hyperintensities in a Young Healthy Population , 2006, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[54]  P. Scheltens,et al.  Age, Hypertension, and Lacunar Stroke Are the Major Determinants of the Severity of Age-Related White Matter Changes , 2006, Cerebrovascular Diseases.

[55]  Roger T Staff,et al.  Brain white matter hyperintensities: relative importance of vascular risk factors in nondemented elderly people. , 2005, Radiology.

[56]  J. Karemaker,et al.  Impaired Cerebral Autoregulation in Patients With Malignant Hypertension , 2004, Circulation.

[57]  P. Bertolucci,et al.  Applicability of the CERAD neuropsychological battery to Brazilian elderly. , 2001, Arquivos de neuro-psiquiatria.

[58]  E Auffray,et al.  Longitudinal study of blood pressure and white matter hyperintensities , 2001, Neurology.

[59]  U. Bille‐Brahe.  The role of sex and age in suicidal behavior , 1993, Acta psychiatrica Scandinavica. Supplementum.

[60]  J. V. van Swieten,et al.  Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. , 1991, Brain : a journal of neurology.

[61]  C. Marks,et al.  A Clinicopathologic Study , 2017 .

[62]  M. Jokela,et al.  The Whitehall II Study , 2009 .

[63]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[64]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[65]  K. Johnson.  An Update. , 1984, Journal of food protection.

[66]  P. Freedson,et al.  Scientific Statement From the American Heart Association Guide to the Assessment of Physical Activity: Clinical and Research Applications: A , 2015 .